Looking for a Wegovy deal? Here's what UK pricing really covers

What drives the cost of Wegovy in the UK private market

Eli Lilly's September 2025 list-price increase for tirzepatide made headlines, but Wegovy (semaglutide) pricing has followed its own trajectory. Widely reported figures since that period put private Wegovy costs at roughly £149–£375 per month across different providers and doses, though this varies and those figures should be treated as indicative rather than definitive. The dose matters: you start on 0.25mg and titrate upward over several months, so what you pay at the beginning of treatment is not what you pay at maintenance, a fact that monthly headline prices can obscure.

Novo Nordisk manufactures Wegovy and supplies it through the licensed UK supply chain. A legitimate private prescription must come from a regulated UK pharmacy you can verify on the GPhC pharmacy register. If you cannot find a seller on that register, stop. The MHRA has documented large seizures of counterfeit weight-loss pens (fake products have contained insulin) and has warned specifically about sellers offering these medicines without a prescription via social media and unofficial websites.

The full picture on Wegovy pricing covers what influences cost month to month, including dose changes and what to ask any provider before committing.

What headline prices often leave out

A number in an ad is rarely the number you pay. Some private providers charge separately for the initial consultation, the prescription fee, and delivery, each a modest-sounding line item that adds up. Aftercare, which matters a great deal on a medicine with a GI-heavy side-effect profile, is sometimes billed per contact or simply absent. Dose-review support (the clinical check before your prescriber authorises a higher dose) may be treated as an optional extra.

If you experience nausea or other early side effects and need guidance, that support has to come from somewhere. Our guide to managing Wegovy side effects covers the practical steps, and if you are specifically struggling with changes to your digestion you may find our advice on how to deal with Wegovy constipation useful alongside our practical guidance on how to deal with nausea from semaglutide, the most common early complaint. The point is: these are real clinical events that require real clinical support, and whether that support is included in your price matters.

The Wegovy treatment overview sets out the full titration schedule and what to expect at each stage, which makes cost comparisons easier when you know what you are actually comparing.

Where nume sits on price, and why

We will be honest: cheapest isn't a race we entered. The single price you pay at nume covers the free consultation, the prescription, the medicine itself, tracked next-working-day DPD delivery in plain packaging, and seven-day-a-week aftercare, including clinical re-review before every repeat order. There is no subscription. There is no auto-renewal. If our prescribers do not think Wegovy is right for you at that point, they say so.

We know that feels frustrating when you are already confident this is the right route. Many people who come to us have already spent months researching, comparing, waiting on NHS lists, or both. That frustration is understandable. Our answer to it is not a discount, it is a faster, safer, cleaner process: order before 12pm on a working day, receive same-day clinical review from a GPhC-registered Independent Prescriber, and if approved, your treatment dispatches the same day. Our FAQs cover the most common questions about the process if you want more detail before starting.

We do not run discount codes, vouchers, or promotional pricing for prescription medicines. If you have seen a code for Wegovy from an online seller, treat it as a red flag rather than a saving, the MHRA's guidance on reporting suspect sellers via Yellow Card is the right next step in that situation.

Why 'cheapest' is the wrong test for a prescription medicine

Wegovy is a Black Triangle medicine under additional MHRA monitoring. It is licensed for weight management in adults with a BMI of 30 or above, or 27 and above with a weight-related health condition, and it requires ongoing prescriber oversight, NICE's appraisal of semaglutide for weight management (NICE TA875) specifically recommends it within a managed clinical pathway. The lowest-price listing on a comparison site cannot tell you whether the pharmacy is GPhC-registered, whether a real prescriber reviewed your case, or whether what arrives is genuine medicine from the authorised supply chain.

The right metric is not the price; it is what that price buys in terms of safety, legitimacy, and clinical support. For anyone weighing up their options, the weight-loss treatment overview sets out the full landscape, and when you are ready to take the clinical step, checking your eligibility takes a few minutes with no obligation.